国科恒泰:2024年报净利润1.31亿 同比下降14.94%

Financial Performance - The basic earnings per share decreased by 22.22% from 0.36 yuan in 2023 to 0.28 yuan in 2024 [1] - Operating revenue fell by 1.83% from 74.83 billion yuan in 2023 to 73.46 billion yuan in 2024 [1] - Net profit decreased by 14.94% from 1.54 billion yuan in 2023 to 1.31 billion yuan in 2024 [1] - Return on equity dropped by 35.13% from 8.17% in 2023 to 5.30% in 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 18,437.1 million shares, accounting for 56.94% of the circulating shares, with a decrease of 1,507.37 million shares compared to the previous period [1] - The largest shareholder, Holguos Hongsheng Ruitai Equity Investment Management Partnership, holds 6,364.74 million shares, representing 19.66% of the total share capital [2] - The second-largest shareholder, Taikang Life Insurance Co., Ltd., holds 3,641.69 million shares, accounting for 11.25% of the total share capital [2] Dividend Distribution - The company announced a dividend distribution plan of 0.84 yuan per share (including tax) [3]

GKHT Medical Technology -国科恒泰:2024年报净利润1.31亿 同比下降14.94% - Reportify